Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases

This publication has 59 references indexed in Scilit:

• Synaptic changes in Alzheimer’s disease and its models
  Neuroscience, 2013
• Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease
  Neurobiology of Aging, 2013
• Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival
  Cellular and Molecular Life Sciences, 2013
• Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease
  Journal of Neurochemistry, 2011
• Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease
  PLOS ONE, 2011
• PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury
  PLOS ONE, 2011
• Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
  Neuropharmacology, 2010
• Synthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 Inhibitors
  ChemMedChem, 2009
• Phosphorylation of the cAMP-dependent Protein Kinase (PKA) Regulatory Subunit Modulates PKA-AKAP Interaction, Substrate Phosphorylation, and Calcium Signaling in Cardiac Cells
  Journal of Biological Chemistry, 2008
• Identification of Human PDE7B, a cAMP-Specific Phosphodiesterase
  Biochemical and Biophysical Research Communications, 2000